FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 30

Author

Admin 422 posts 0 comments

Featured News

Finance Process Improvement & the Global Process Owner Role

Admin Mar 4, 2025
This webinar, scheduled for October 31, 2024, will provide finance leaders with a comprehensive understanding of…
Whitepaper

The future of financial services: better customer experiences start with…

Admin Mar 3, 2025
Over the last few years, consumers have shown extraordinary resilience through much uncertainty. Many have adapted…
Featured News

How Fintech and AI Have Joined Forces to Improve Back-Office Operations

Admin Feb 28, 2025
The fintech industry is constantly bringing new ideas to the fore that have the potential to take off. While some…
Whitepaper

The Power of Ecosystems for Banking

Admin Feb 27, 2025
The rise of Banking as a Service (BaaS) and real-time payments (RTP) are pushing the era of digitalization to new…
Articles

SIP vs. Mutual Fund: Understanding the Differences

Admin Feb 26, 2025
Introduction Investing is a crucial part of financial planning, and mutual funds are one of the most…
Featured News

World Bank President Ajay Banga Unveils Plans to Address Climate Change and Boost…

Admin Feb 25, 2025
Introduction In a significant step toward tackling global challenges, World Bank President Ajay Banga has…
Whitepaper

US investment trends report 2025

Admin Feb 24, 2025
64% of Americans are likely to invest in 2025. Who are they? 84% of Gen Z investors view cryptocurrency as a…
Whitepaper

The New Era of Financial Operations Management

Admin Feb 21, 2025
The need to accelerate the journey to financial operations excellence has seen the emergence of packaged,…
Whitepaper

The Future of Neobanking: How can Neobanks unlock profitable growth?

Admin Feb 20, 2025
Few developments within financial services have happened with such breathtaking speed as the evolution of…
Whitepaper

The digital finance mandate: Transforming the office of finance in financial…

Admin Feb 19, 2025
For the last few years, Financial Services CFOs and their finance teams have been tasked with implementing a…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • India’s Financial Revolution in 2026: How Digital Payments, Investments, and New Policies Are Reshaping the Economy
    • How to generate business growth with subscriptions
    • Understanding Banking Loans: A Comprehensive Guide
    • Understanding Credit Card Frauds: Types, Impact, and Prevention
    • Blackhawk Network Buys DIDIX Gifting & Promotions, a Dutch Company

    ARTICLE

    Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
    2026-06-29T13:13:13Z
    GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic Preparedness...


    SPR Wins Fifth Consecutive Northeast Ohio Top Workplaces Award
    2026-06-29T13:00:00Z
    CLEVELAND, Ohio, June 29, 2026 (GLOBE NEWSWIRE) -- SPR has been recognized as a Top Workplace by Northeast Ohio Top Workplaces for the fifth consecutive year, marking a significant milestone...


    Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
    2026-06-29T13:00:00Z
    Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.


    Tria Federal Earns Three Positions on NASA SEWP VI Government-Wide IT Contract
    2026-06-29T12:47:00Z
    Awards position Tria and its joint ventures to serve federal health and public safety agencies across the full spectrum of IT and enterprise technology needs


    Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector
    2026-06-29T12:45:00Z
    VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices,...


    Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026
    2026-06-29T12:45:00Z
    First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics Profile


    Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
    2026-06-29T12:45:00Z
    Consolidated closing of recently announced $5.5 million PIPE led by existing investors, combined with an additional $2.8 million in proceeds from warrant exercises, results in approximately $8.3 million of capital...


    Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
    2026-06-29T12:44:00Z
    Raanana, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, announced it...


    Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
    2026-06-29T12:35:00Z
    FORT LAUDERDALE, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT), an early-stage biotechnology company developing novel therapeutics, today announced a new preclinical statistical analysis of liver...


    New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
    2026-06-29T12:30:00Z
    PRINCETON, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced positive results from PROSPER, a real-world...


    Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
    2026-06-29T12:30:00Z
    Experienced Industry Leader Brings Two Decades of Finance, Strategic and Operational Expertise


    Achieve Life Sciences Joins Russell 2000® Index
    2026-06-29T12:30:00Z
    SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...


    Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003
    2026-06-29T12:30:00Z
    Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic Therapeutics


    Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
    2026-06-29T12:30:00Z
    ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America and Europe


    TOMI Environmental Solutions Announces Definitive Agreement to Merge with Carbonium Core
    2026-06-29T12:30:00Z
    Transaction will create a public market pure-play on America's nuclear renaissance, positioned at the intersection of AI-driven power demand, advanced nuclear reactors, and domestic critical materials production


    Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
    2026-06-29T12:30:00Z
    June 29, 2026


    Novo Nordisk A/S - share repurchase programme
    2026-06-29T12:10:27Z
    Bagsværd, Denmark, 29 June 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament...


    VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
    2026-06-29T12:05:00Z
    VivoSim Demonstrates Leadership in Field through AI-enabled NAMkind™ Liver and Intestine with High Accuracy Results, Including for Antibody Drug Conjugates (ADCs)


    Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
    2026-06-29T12:01:00Z
    LEXINGTON, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced a Developing Topics (late-breaking)...


    Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
    2026-06-29T12:00:00Z
    BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that the...


    4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
    2026-06-29T12:00:00Z
    EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to...


    Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
    2026-06-29T12:00:00Z
    NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward...


    GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"
    2026-06-29T12:00:00Z
    BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. ("GuideAI" or the "Company") (Cboe CA: GDAI) is pleased to report that the Company has received final approval to list...


    Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer
    2026-06-29T12:00:00Z
    SAN JOSE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”; “Rani” or the “Company”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery...


    4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
    2026-06-29T12:00:00Z
    EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to...


    IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
    2026-06-29T12:00:00Z
    NASHVILLE, Tenn., June 29, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that its Chief Science Officer, Prof. Dr. Ekkehard Schuetz. M.D., Ph.D., has published...


    HealthLynked Launches AI-Powered Healthcare Communication Platform Featuring 24/7 Appointment Scheduling and Medical Office AI Agents
    2026-06-29T12:00:00Z
    NAPLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- via IBN – HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology, patient engagement, and care coordination, today announced the launch of its...


    Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
    2026-06-29T12:00:00Z
    WOBURN, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for...


    Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
    2026-06-29T12:00:00Z
    Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial


    Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
    2026-06-29T11:55:00Z
    Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic,...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.